Search results
Found 6703 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Opportunities for final goodbyes must be prioritised in COVID-19 pandemic
Coronavirus COVID-19 General Research
31 March 2021
Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.
New study shows overwhelming public support for donating vaccines to low-income countries
Coronavirus COVID-19 General Research
31 March 2021
A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.
New target identified to develop treatment for Abdominal Aortic Aneurysm
General Research
30 March 2021
A new study from the Department of Physiology, Anatomy & Genetics (DPAG) has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.
Food and drink products with pro-environment ‘ecolabels’ are more appealing to shoppers – new research
General Research
29 March 2021
MRC HIU researchers release cheap, quick COVID-19 antibody test
Coronavirus COVID-19 General Research
29 March 2021
An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19.
New study finds strong immune response following COVID-19 vaccination
Coronavirus COVID-19 General Research
29 March 2021
A new study has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine, and that after two doses levels of protection were even stronger.
University of Oxford to study nasal administration of COVID-19 vaccine
Clinical Trials Coronavirus COVID-19 General
26 March 2021
The University of Oxford is launching a study investigating the delivery of the ChAdOx1 nCoV-19 coronavirus vaccine using a nasal spray.
AstraZeneca publish primary analysis from US trial of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
25 March 2021
Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.
New partnership enables access to state-of-the-art radiotherapy machine
General Research
25 March 2021
The first NHS patient has received treatment on the cutting-edge ViewRay MRIdian technology, thanks to a new partnership between the University of Oxford, Oxford University Hospitals (OUH) NHS Foundation Trust and GenesisCare.
World TB Day: Finding new ways to test children for tuberculosis
General Research
24 March 2021
Dr Nisreen Khambati of the Oxford Vaccine Group writes for the Oxford Science Blog on why it is vital to find new ways to test children for tuberculosis.
Marking 100 years of the tuberculosis BCG vaccine
General
24 March 2021
The VALIDATE Network, a community of over 400 researchers based in more than 200 research institutions in 63 countries, will today launch the “BCG100 Programme” marking the centenary of the Bacille Calmette-Guérin Vaccine for tuberculosis.
The RECOVERY Trial: One year on
Coronavirus COVID-19 General Research
23 March 2021
The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial was officially launched on 23 March 2020. It is the world's largest COVID-19 drug trial.
COVID-19: how to tackle vaccine hesitancy among BAME groups
Coronavirus COVID-19 General Research
22 March 2021
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Clinical Trials Coronavirus COVID-19 General Research
22 March 2021
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Oxford awarded major funding to probe childhood poverty and social inequalities
Awards and Appointments General Research
19 March 2021
Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
Awards and Appointments General Innovation Research
18 March 2021
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Two doses of vaccine offer same protection from COVID as prior infection, study finds
Coronavirus COVID-19 General Research
15 March 2021
Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found.